NRC/SECY/RAS
From kanterella
Jump to navigation
Jump to search
(NRC/SECY/RAS) | |
|---|---|
| HQ Office | |
Region 1Division
Branch
Region 2Division
Branch
Region 3Division
Branch
Region 4Division
Branch
| |
| [from] | MONTHYEARML24351A0312024-12-160Issue date: 16 December 2024 Title: Licensing Support Network Advisory Review Panel (Lsnarp); Notice of Renewal ML24340A0962024-12-020Issue date: 2 December 2024 Title: 12-02-24 Advisory Committee on Reactor Safeguards: Charter Renewal ML24289A1952024-10-090Issue date: 9 October 2024 Title: Follow-up Email Dated October 9, 2024 from the Office of the Secretary to Wallace Taylor Regarding the Filing Error ML24289A1942024-10-080Issue date: 8 October 2024 Title: Email Dated October 8, 2024 from the Office of the Secretary to the Participants of the Palisades 50-255 & 72-007 LT-3 Proceeding Regarding Filing Error ML24289A1932024-10-080Issue date: 8 October 2024 Title: Email Dated October 9, 2024 from the Office of the Secretary to Wallace Taylor Regarding Filing Error ML24184A4752024-07-090Issue date: 9 July 2024 Title: ACMUI Notice of Meeting August 29 2024 ML24149A3542024-05-290Issue date: 29 May 2024 Title: ACMUI Notice of Meeting June 17 2024 ML24137A0182024-05-160Issue date: 16 May 2024 Title: ACMUI Notice of Meeting June 5 2024 Correction ML24122C6792024-05-020Issue date: 2 May 2024 Title: ACMUI Notice of Meeting June 5 2024 ML24067A0902024-03-050Issue date: 5 March 2024 Title: Email to Diane Curran from the Office of the Secretary, Assistant for Rulemaking and Adjudications, Russell Chazell ML24061A2272024-03-040Issue date: 4 March 2024 Title: ACMUI Notice of Meeting April 8-9 2024 ML24059A0272024-02-280Issue date: 28 February 2024 Title: 02-28-24 Advisory Committee on the Medical Uses of Isotopes (Acmui); Charter Renewal ML24059A1232024-02-280Issue date: 28 February 2024 Title: Advisory Committee on the Medical Uses of Isotopes: Charter Renewal ML24059A1242024-02-280Issue date: 28 February 2024 Title: Charter for the Advisory Committee on the Medical Uses of Isotopes ML24059A1282024-02-280Issue date: 28 February 2024 Title: Letter to the Library of Congress, Federal Advisory Committee Desk, Mr. Miroslav Lazarevich Regarding the Advisory Committee on the Medical Uses of Isotopes Renewed Charter ML24053A3602023-12-010Issue date: 1 December 2023 Title: 2023 Annual Report - Review of Federal Advisory Committee ML23128A0942023-05-090Issue date: 9 May 2023 Title: 706th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, June 7-9, 2023 ML23104A0622023-05-010Issue date: 1 May 2023 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Notice of Meeting, May 15-16, 2023 ML23074A1112023-03-140Issue date: 14 March 2023 Title: Office of the Secretary Email Regarding Filing of Hearing Request from San Luis Obispo Mothers for Peace Regarding Diablo Canyon ISFSI License Renewal Application ML23061A1642023-03-010Issue date: 1 March 2023 Title: Email Transmitting a Copy of the Order of the Secretary Denying Petition for Declaratory Order to Representatives of the Applicant ML23040A3392023-02-090Issue date: 9 February 2023 Title: Official Exhibit - PSO004-00-BD01 - Usdoe Office of Civilian Radioactive Waste Management Acceptance Priority Ranking and Annual Capacity Report. March 1995 ML23040A3412023-02-090Issue date: 9 February 2023 Title: Certificate of Service for Presiding Officer Exhibit (PSO004) ML22363A1892022-12-160Issue date: 16 December 2022 Title: Letter to the Library of Congress Providing Copy of 2023 Charter Renewal for the Licensing Support Network Advisory Review Panel ML22363A1912022-12-160Issue date: 16 December 2022 Title: 2023 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML22363A1922022-12-160Issue date: 16 December 2022 Title: 2023 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML22363A1932022-12-160Issue date: 16 December 2022 Title: Federal Register Notice for the 2023 FACA Charter Renewal of the Licensing Support Network Advisory Review Panel ML22357A0512022-12-020Issue date: 2 December 2022 Title: Letter to the Library of Congress from Russell Chazell, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0502022-12-020Issue date: 2 December 2022 Title: 2022 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML22357A0462022-12-020Issue date: 2 December 2022 Title: Letter to the Honorable Frank Pallone, Jr. from Eugene Dacus, OCA, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0472022-12-020Issue date: 2 December 2022 Title: Letter to the Honorable Thomas R. Carper from Eugene Dacus, OCA, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0482022-12-020Issue date: 2 December 2022 Title: Federal Register Notice for the 2022 FACA Charter Renewal of the Advisory Committee on Reactor Safeguards ML22357A0492022-12-020Issue date: 2 December 2022 Title: 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML24053A3592022-12-010Issue date: 1 December 2022 Title: 2022 Annual Report - Review of Federal Advisory Committee ML22271A9762022-09-280Issue date: 28 September 2022 Title: Action Referral - Appeal of Denial of SUNSI Access - Nuclear Fuel Services, Inc. License Amendment Application ML22256A2402022-09-140Issue date: 14 September 2022 Title: 699th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, October 5-7, 2022 ML22216A0322022-08-050Issue date: 5 August 2022 Title: 698th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, September 7-9, 2022 ML22041A4552022-02-080Issue date: 8 February 2022 Title: M220208: Transcript - Meeting with the Organization of Agreement States and the Conference of Radiation Control Program ML24053A3582021-12-010Issue date: 1 December 2021 Title: 2021 Annual Report - Review of Federal Advisory Committee ML20366A0312020-12-300Issue date: 30 December 2020 Title: Federal Register Notice for the 2021 FACA Charter Renewal of the Licensing Support Network Advisory Review Panel ML20366A0282020-12-300Issue date: 30 December 2020 Title: 2021 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML20366A0292020-12-300Issue date: 30 December 2020 Title: Letter to the Library of Congress Providing Copy of 2021 Charter Renewal for the Licensing Support Network Advisory Review Panel ML20366A0302020-12-300Issue date: 30 December 2020 Title: 2021 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML20337A1192020-12-020Issue date: 2 December 2020 Title: Letter to the Library of Congress from Russell Chazell, Providing the 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML20337A1182020-12-020Issue date: 2 December 2020 Title: 2020 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML20337A1172020-12-020Issue date: 2 December 2020 Title: 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML20337A1162020-12-020Issue date: 2 December 2020 Title: Federal Register Notice for the 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML24053A3632020-12-010Issue date: 1 December 2020 Title: 2020 Annual Report - Review of Federal Advisory Committee ML20325A2552020-11-200Issue date: 20 November 2020 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Call for Nominations for Patients Rights Advocate ML20220A6752020-08-070Issue date: 7 August 2020 Title: Memo to File Regarding Withdrawal of Comment Request Submitted by Lisa E. Gordon-Hagerty on Behalf of National Nuclear Security Administration ML20190A1272020-07-230Issue date: 23 July 2020 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Meeting Notice for September 21-22, 2020 ML20064F8502020-02-280Issue date: 28 February 2020 Title: Letter to the Library of Congress Providing Copy of 2020 FACA Charter Renewal for the Advisory Committee on the Medical Use of Isotopes ML20064F8522020-02-280Issue date: 28 February 2020 Title: 2020 Membership Balance Plan for the Advisory Committee on the Medical Uses of Isotopes ML20064F8512020-02-280Issue date: 28 February 2020 Title: 2020 FACA Charter Renewal for the Advisory Committee on the Medical Uses of Isotopes ML20064F8482020-02-280Issue date: 28 February 2020 Title: Letter to the Honorable John Barrasso from Eugene Dacus, OCA, Providing Copy of the 2020 FACA Charter Renewal for the Advisory Committee on Medical Uses of Isotopes ML20065H1642020-02-280Issue date: 28 February 2020 Title: 02-28-20 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Charter Renewal - Notice of Renewal Until February 28, 2022 ML24053A3622019-12-020Issue date: 2 December 2019 Title: 2019 Annual Report - Review of Federal Advisory Committee ML19261A8602019-09-180Issue date: 18 September 2019 Title: Clinch River Mandatory Hearing on Early Site Permit - Information Regarding Location/Cross References of Hearing Transcript and Transcript Corrections ML19106A2572019-01-030Issue date: 3 January 2019 Title: Letters to the Honorable John Barrasso and Frank Pallone from Eugene Dacus, OCA, Providing Copy of 2019 Charter Renewal for the Licensing Support Network Advisory Review Panel ML19106A2562019-01-030Issue date: 3 January 2019 Title: Letter to the Library of Congress Providing Copy of 2019 Charter Renewal for the Licensing Support Network Advisory Review Panel ML19106A2552019-01-030Issue date: 3 January 2019 Title: 2019 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML19106A2542019-01-030Issue date: 3 January 2019 Title: 2019 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML24053A3612018-12-030Issue date: 3 December 2018 Title: 2018 Annual Report - Review of Federal Advisory Committee ML19106A2162018-12-030Issue date: 3 December 2018 Title: 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML19106A2172018-12-030Issue date: 3 December 2018 Title: 2018 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML19106A2182018-12-030Issue date: 3 December 2018 Title: Letter to the Library of Congress Providing Copy of 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML19106A2192018-12-030Issue date: 3 December 2018 Title: Letters to the Honorable John Barrasso and Greg Walden from Eugene Dacus, OCA, Providing the 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML18149A5962018-05-260Issue date: 26 May 2018 Title: Comment (020) from an Anonymous Individual on the Requirements for the Indefinite Storage of Spent Nuclear Fuel ML18107A8092018-03-280Issue date: 28 March 2018 Title: E-mail from Brian Newell, Nrc/Secy, to NRC Licensing Support Network Advisory Review Panel (LSNARP) Staff, Regarding Status Update for Prairie Island Indian Community and White Pine County, Nv Comments Following February 27-28, 2018 LSNARP ML19107A1302018-03-010Issue date: 1 March 2018 Title: Letter to the Library of Congress Providing Copy of 2018 FACA Charter Renewal for the Advisory Committee on the Medical Use of Isotopes ML19107A0432018-03-010Issue date: 1 March 2018 Title: 2018 Membership Balance Plan for the Advisory Committee on the Medical Uses of Isotopes ML19107A0442018-03-010Issue date: 1 March 2018 Title: 2018 FACA Charter Renewal for the Advisory Committee on the Medical Uses of Isotopes DD-17-04, Letters to Licensees Omitted from Distribution of Order Extending Commission Review Time for Directors Decision DD-17-042018-01-100Issue date: 10 January 2018 Title: Letters to Licensees Omitted from Distribution of Order Extending Commission Review Time for Directors Decision DD-17-04 ML17353A1962017-12-180Issue date: 18 December 2017 Title: E-mail to LSNARP Members Regarding Licensing Support Network Advisory Review Panel Meeting - Federal Register Notice ML17353A1982017-12-180Issue date: 18 December 2017 Title: Attachment 3 - Instructions for Virtual Meeting Attendance Via Gotomeeting by LSNARP Member Representatives ML16182A4182016-06-300Issue date: 30 June 2016 Title: June 20, 2016 Service of Commission Meeting Transcript ML14321A7422014-11-170Issue date: 17 November 2014 Title: Letter from Emile Julian to Timothy Rausch Providing Comments from Eric Epstein Regarding Susquehanna Steam Electric Station, Units 1 and 2 and ISFSI; Application for License Transfer ML14308A6402014-11-030Issue date: 3 November 2014 Title: Letter from Emile Julian to Timothy Rausch Providing Comments Submitted Regarding Susquehanna Steam Electric Station, Units 1 and 2 and ISFSI; Application for License Transfer ML14182A6072014-07-010Issue date: 1 July 2014 Title: Notice of Service of Commission Meeting Transcript ML14101A3882014-04-110Issue date: 11 April 2014 Title: Service of Commission Meeting Transcript M130108, SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners' Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance)2013-01-220Issue date: 22 January 2013 Title: SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners' Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance) ML13022A4282013-01-220Issue date: 22 January 2013 Title: SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance) SECY-12-0135, M121012 - Affirmation Session: SECY-12-0135 - Entergy Nuclear Operations, Inc. (Indian Point Units 2 and 3) - Entergys Petition for Interlocutory Review of Board Order Granting Cross-Examination to New York State and Entergys Stay Reque2012-10-120Issue date: 12 October 2012 Title: M121012 - Affirmation Session: SECY-12-0135 - Entergy Nuclear Operations, Inc. (Indian Point Units 2 and 3) - Entergys Petition for Interlocutory Review of Board Order Granting Cross-Examination to New York State and Entergys Stay Request ML12276A4042012-10-020Issue date: 2 October 2012 Title: Note to the Parties Non-Public Copyright Exhibits List ML12258A3412012-09-120Issue date: 12 September 2012 Title: Limited Appearance Statement of Jessica Winston Opposing Indian Point, Units 2 and 3 License Renewal Application ML12024A4332012-01-180Issue date: 18 January 2012 Title: Transcript of the Entergy Nuclear Operations, Inc., Indian Point, Units 2 & 3, Pre-Hearing Conference, Wednesday, January 18, 2012, Pages 1054-1100 ML1103200832011-01-120Issue date: 12 January 2011 Title: Email to Robert Leyse Regarding His Submission of January 11, 2011 ML0823410512008-08-210Issue date: 21 August 2008 Title: Commission Order - Oyster Creek ML0823407172008-08-190Issue date: 19 August 2008 Title: Julian Email to Saporito Regarding Petition Submission ML0823304172008-08-120Issue date: 12 August 2008 Title: NRC Staff Exhibit List - Vermont Yankee Nuclear Power Station July 2008 Evidentiary Hearing ML0823304192008-08-120Issue date: 12 August 2008 Title: July 2008 Evidentiary Hearing, New England Coalition Exhibit List ML0726205492007-09-110Issue date: 11 September 2007 Title: Request for Extension of Time to File Hearing Request, by Alison H. Crocker, New York State Dept. of Environmental Conservation ML0619303662006-06-260Issue date: 26 June 2006 Title: Transcript of Limited Appearance Statements Held in Brattleboro, VT; pp.1 - 94 ML0527201292005-09-280Issue date: 28 September 2005 Title: Letter from Emile L. Julian Diane Curran Requesting Return of Safeguards Documents ML0418905592004-07-070Issue date: 7 July 2004 Title: Commission Memorandum and Order (CLI-04-18) ML0418905642004-07-070Issue date: 7 July 2004 Title: Commission Memorandum and Order (CLI-04-19) ML0418106512004-06-250Issue date: 25 June 2004 Title: Letter from Annette L. Vietti-Cook to Mitchell Mickey J. Maricque Responding to His Request for a Hearing ML0234003322002-12-060Issue date: 6 December 2002 Title: Memorandum from Emile L. Julian to Recipients of Letter Dated 12/04/02 from Annette L. Vietti-Cook to Norm Cohen Regarding DD-02-03 ML0212702452002-05-020Issue date: 2 May 2002 Title: Letter Acknowledging Receipt of Ltr. from Laura Stamas Sent to Chairman Meserve Regarding Vermont Yankee Nuclear Power Plant 2024-07-09 |
| [to] | MONTHYEARML25254A0542025-09-110Issue date: 11 September 2025 Title: Written Limited Appearance Statement from John Kleb ML25206A1452025-07-250Issue date: 25 July 2025 Title: Non-Disclosure Agreements - San Antonio Bay Estuarine Waterkeeper - Marisa Perales Et Al ML25147A0242025-05-270Issue date: 27 May 2025 Title: Eric Joseph Epsteins Request to Bar Receipt of New Fuel to Support Potential Restart of the Facility ML25083A2312025-03-210Issue date: 21 March 2025 Title: Comment (008) from Judi Greenwald on Behalf of Nuclear Innovation Alliance on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25083A2372025-03-210Issue date: 21 March 2025 Title: Comment (014) from David Terry on Behalf of the National Association of State Energy Officials (Naseo) on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25083A2362025-03-200Issue date: 20 March 2025 Title: Comment (013) from Gabrielle Schreier on Behalf of GE Hitachi Nuclear Energy on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25073A0122025-03-130Issue date: 13 March 2025 Title: Comment (004) from Wayne A. Norton on Behalf of Decommissioning Plant Coalition (DPC) on PR-170 and 171 - Fee Schedules Fee Recovery for Fiscal Year 2025 ML25072A0252025-03-030Issue date: 3 March 2025 Title: Comment (012) from Alyse Peterson on Behalf of New York State Energy Research and Development Authority (NYSERDA) on PR-73 - Law Enforcement Response in Power Reactor ML25063A0062025-03-030Issue date: 3 March 2025 Title: Comment (010) from David Young on Behalf of Nuclear Energy Institute on PR-73 - Law Enforcement Response in Power Reactor Physical Protection Programs ML25044A4192025-02-110Issue date: 11 February 2025 Title: Comment (075) from Lizzie Mcfee on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors NRC-2024-0173, Comment (016) from Kimberly D. Hulvey on Behalf of Tennessee Valley Authority (TVA) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors2025-02-100Issue date: 10 February 2025 Title: Comment (016) from Kimberly D. Hulvey on Behalf of Tennessee Valley Authority (TVA) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A6002025-02-100Issue date: 10 February 2025 Title: Comment (019) from Kenneth A. Mack on Behalf of Florida Power & Light and NextEra on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A5602025-02-100Issue date: 10 February 2025 Title: Comment (015) from Shawn K. Gibby on Behalf of Duke Energy on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A5852025-02-060Issue date: 6 February 2025 Title: Comment (017) from Jamie M. Coleman on Behalf of Southern Nuclear Operating Company (SNC) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A0942025-02-060Issue date: 6 February 2025 Title: Comment (014) from Mitch S. Dior on Behalf of BWR Owners Group (BWROG) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25037A2332025-02-060Issue date: 6 February 2025 Title: Comment (011) by Victoria Anderson on Behalf of Nuclear Energy Institute (NEI) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25038A1292025-02-050Issue date: 5 February 2025 Title: Comment (013) from Jim Lynde on Behalf of Pressurized Water Reactor (PWR) Owners Group on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25038A1282025-02-040Issue date: 4 February 2025 Title: Comment (012) from David Mannai on Behalf of PSEG Nuclear, LLC on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25036A0082025-01-300Issue date: 30 January 2025 Title: Comment (010) by James E. Holloway on Behalf of Dominion Energy Services, Inc. on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25083A0672025-01-270Issue date: 27 January 2025 Title: Comment (022) from Kevin Lueshen on Behalf of Constellation Energy Generation, LLC on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25027A4142025-01-270Issue date: 27 January 2025 Title: Comment (008) from Michael K. Scarpello on Behalf of Indiana Michigan Power Company (I&M) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25031A0052025-01-240Issue date: 24 January 2025 Title: Comment (009) from Michael D. Dilorenzo on Behalf of Arizona Public Service Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25024A0102025-01-230Issue date: 23 January 2025 Title: Comment (007) from A.M. Richards, Jr. on Behalf of STP Nuclear Operating Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25022A3062025-01-220Issue date: 22 January 2025 Title: Letter from T. Basso, NEI to C. Araguas Regarding Request for Input and Comment on Current 10 CFR 55a Rulemaking ML25024A0082025-01-220Issue date: 22 January 2025 Title: Comment (005) from Linda Dewhirst on Behalf of Nebraska Public Power District on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25065A0342025-01-220Issue date: 22 January 2025 Title: Petition for Rulemaking from Thomas Basso on Behalf of the Nuclear Energy Institute to Revise Industry Codes and Standards for Production and Utilization Facilities ML25024A0092025-01-220Issue date: 22 January 2025 Title: Comment (006) from Sara L. Scott on Behalf of Northern States Power Company (Xcel Energy) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1782025-01-100Issue date: 10 January 2025 Title: Comment (047) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A0302025-01-100Issue date: 10 January 2025 Title: Comment (004) from Peter Dietrich on Behalf of DTE Electric Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1772025-01-090Issue date: 9 January 2025 Title: Comment (046) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A0162025-01-090Issue date: 9 January 2025 Title: Comment (003) from Donald Hoffman on Behalf of Excel Services Corporation on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1762025-01-080Issue date: 8 January 2025 Title: Comment (045) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A1752025-01-080Issue date: 8 January 2025 Title: Comment (044) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25002A2342025-01-020Issue date: 2 January 2025 Title: Comment (002) from Philip Couture on Behalf of Entergy on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1792025-01-020Issue date: 2 January 2025 Title: Comment (048) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML24354A0672024-12-180Issue date: 18 December 2024 Title: Comment (031) from M. Oneill on Behalf of NEI on PR-51 -Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24353A3052024-12-180Issue date: 18 December 2024 Title: Comment (024) from Emy Lesofski on Behalf of Utah Office of Energy Development on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24354A0512024-12-180Issue date: 18 December 2024 Title: Comment (028) from Alyse Peterson on Behalf of NYSERDA on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24353A2362024-12-180Issue date: 18 December 2024 Title: Comment (021) from Anthony Schoedel on Behalf of Westinghouse Electric Company on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24354A0612024-12-180Issue date: 18 December 2024 Title: Comment (030) from Peter Hastings on Behalf of Kairos Power, LLC on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML25015A1382024-12-130Issue date: 13 December 2024 Title: Comment (036) by S. Reynolds on Behalf of the Illinois Emergency Management Agency and Office of Homeland Security (IEMA-OHS) on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24345A1932024-11-240Issue date: 24 November 2024 Title: Comment (030) from Tom Gurdziel on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25015A1032024-11-200Issue date: 20 November 2024 Title: Comment (049) from Tom Gurdziel on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML24297A4262024-10-230Issue date: 23 October 2024 Title: Comment (006) from Christopher P. Chwasz on Behalf of the Advanced Reactor Regulatory Coordination and Integration Group on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24298A0672024-10-230Issue date: 23 October 2024 Title: Comment (012) from the Council of Intelligent Energy & Conservation Policy and Promoting Health and Sustainable Energy on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24312A3362024-10-230Issue date: 23 October 2024 Title: Comment (015) from Alyse Peterson on Behalf of the New York State Research and Development Authority on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24298A0662024-10-230Issue date: 23 October 2024 Title: Comment (011) from Edwin Lyman on Behalf of the Union of Concerned Scientists on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24295A0342024-10-170Issue date: 17 October 2024 Title: Comment (003) from Anthony J. Schoedel on Behalf of Westinghouse Electric Company on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24289A1962024-10-100Issue date: 10 October 2024 Title: Email Dated October 10, 2024 from Wallace Taylor Indicating His Intention to Refile ML24264A1122024-09-200Issue date: 20 September 2024 Title: Comment (008) from Martin J. Oneill on Behalf of the Nuclear Energy Institute on PR-51 - Categorical Exclusions from Environmental Review ML24250A0072024-09-160Issue date: 16 September 2024 Title: Designation of Federal Employees as the Dfo for the ACMUI ML24262A2522024-09-160Issue date: 16 September 2024 Title: Comment (007) from the Nuclear Energy Tribal Working Group on PR-51 - Categorical Exclusions from Environmental Review TSTF-24-07, PRM-50-126 - Petition for Rulemaking to Amend 10 CFR 50.36, Technical Specifications from Brian D. Mann on Behalf of the Technical Specifications Task Force2024-09-130Issue date: 13 September 2024 Title: PRM-50-126 - Petition for Rulemaking to Amend 10 CFR 50.36, Technical Specifications from Brian D. Mann on Behalf of the Technical Specifications Task Force ML24152A1372024-04-250Issue date: 25 April 2024 Title: Comment (009) from Anthony S. on Behalf of the Nez Perce Tribe on PR-37 - Advance Tribal Notification of Category 1 Quantities of Radioactive Material Shipments ML24082A2292024-03-210Issue date: 21 March 2024 Title: Comment (008) of Nader Mamish on Behalf of Westinghouse Electric Company, LLC, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A0972024-03-210Issue date: 21 March 2024 Title: Comment (005) of Jennifer Uhle on Behalf of the Nuclear Energy Institute on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A2302024-03-210Issue date: 21 March 2024 Title: Comment (009) of Sara L. Scott on Behalf of Xcel Energy/Northern States Power Company - Minnesota, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A2282024-03-210Issue date: 21 March 2024 Title: Comment (007) of Kevin Lueshen on Behalf of Constellation Energy Generation, LLC, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A1912024-03-210Issue date: 21 March 2024 Title: Comment (006) from NextEra Energy Duane Arnold, LLC on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24080A0632024-03-190Issue date: 19 March 2024 Title: Comment (004) of Gary D. Camper on Behalf of Bwx Technologies, Inc. on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24080A0622024-03-150Issue date: 15 March 2024 Title: Comment (003) of Wayne Norton on Behalf of the Decommissioning Plant Coalition on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24067A0892024-03-050Issue date: 5 March 2024 Title: Email Response from Diane Curran to Office of the Secretary, Assistant for Rulemaking and Adjudications, Russell Chazell ML24023A6042024-01-220Issue date: 22 January 2024 Title: Comment (011) from Jennifer Uhle on Behalf of the Nuclear Energy Institute on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML24024A0712024-01-220Issue date: 22 January 2024 Title: Comment (014) from Gayle Elliott on Behalf of Framatome Inc. on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML24016A0272024-01-120Issue date: 12 January 2024 Title: Comment (025) from Todd Pawlicki on Behalf of American Association of Physicists in Medicine on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2152023-12-180Issue date: 18 December 2023 Title: Petitioners Reply in Support of Petition for Leave to Intervene ML23349A1282023-12-150Issue date: 15 December 2023 Title: Comment (017) from Mouaz Al Mallah on Behalf of the American Society of Nuclear Cardiology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2632023-12-150Issue date: 15 December 2023 Title: Comment (020) from Helen Nadel on Behalf of the Society of Nuclear Medicine and Molecular Imaging on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23349A0402023-12-150Issue date: 15 December 2023 Title: Comment (015) from Bob Thomas of Elekta, Inc. on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23349A1272023-12-150Issue date: 15 December 2023 Title: Comment (016) from Laura I. Thevenot on Behalf of the American Society for Radiation Oncology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2622023-12-150Issue date: 15 December 2023 Title: Comment (019) from Glenn M. Sturchio on Behalf of the Mayo Clinic PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23348A1232023-12-140Issue date: 14 December 2023 Title: Comment (011) from Michael P. Roberson on Behalf of the National Institutes of Health on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23331A9652023-11-270Issue date: 27 November 2023 Title: Miami Waterkeeper - Notice of Appearance for Cameron Bills ML23331A9832023-11-270Issue date: 27 November 2023 Title: Exhibit 3 - William K. Nuttle Declaration ML23331A9812023-11-270Issue date: 27 November 2023 Title: Exhibit 18 - Jeff Mitman Declaration ML23331A9782023-11-270Issue date: 27 November 2023 Title: Exhibit 15 - Knutson Et. Al ML23331A9772023-11-270Issue date: 27 November 2023 Title: Exhibit 14 - 161617 MDC Resolution Re FPL CCS Final ML23331A9802023-11-270Issue date: 27 November 2023 Title: Exhibit 17 - Chin_Cooling Canal System at the FPL Turkey Point Power Station ML23331A9752023-11-270Issue date: 27 November 2023 Title: Exhibit 12 - Groundwater Tek Inc - Peer Review Study Final ML23331A9712023-11-270Issue date: 27 November 2023 Title: Request for Hearing and Petition to Intervene Submitted by Miami Waterkeeper ML23331A9722023-11-270Issue date: 27 November 2023 Title: Exhibit 1 - Rachel Silverstein 2023 Standing Declaration ML23331A9742023-11-270Issue date: 27 November 2023 Title: Exhibit 11 - Waterkeeper Foe Center NRDC Scoping Comments Final ML23331A9762023-11-270Issue date: 27 November 2023 Title: Exhibit 13 - ARCADIS-DERM Letter Re FPL Year 4 Raasr Final ML23331A9862023-11-270Issue date: 27 November 2023 Title: Exhibit 6 - Rebert E. Kopp Declaration ML23331A9852023-11-270Issue date: 27 November 2023 Title: Exhibit 5 - Bill Powers Declaration ML23331A9792023-11-270Issue date: 27 November 2023 Title: Exhibit 16 - Fws Species Status Assessment Miami Cave Crayfish ML23331A9842023-11-220Issue date: 22 November 2023 Title: Exhibit 4 - James Fourqurean 2023 Declaration ML23331A9892023-11-150Issue date: 15 November 2023 Title: Exhibit 9 - FPL Turkey Point Remedial Action Annual Status Report Year 5 ML23331A9822023-11-030Issue date: 3 November 2023 Title: Exhibit 2, Request for Hearing and Petition to Intervene Submitted by Miami Waterkeeper ML23296A0792023-10-180Issue date: 18 October 2023 Title: Comment Period Extension Request from the Nuclear Energy Institute on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML23289A1102023-10-160Issue date: 16 October 2023 Title: Comment (002) Dominic Siewko on Behalf of Jubilant Radiopharma on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23198A0942023-07-140Issue date: 14 July 2023 Title: Comment (053) from Alec Gorge on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0932023-07-140Issue date: 14 July 2023 Title: Comment (052) from Meryl Gorge on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0832023-07-130Issue date: 13 July 2023 Title: Comment (043) from Lauren Creel on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0882023-07-130Issue date: 13 July 2023 Title: Comment (048) from Sarah Taggart on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23194A0702023-07-120Issue date: 12 July 2023 Title: Comment (034) from Esther E. Sciammarella on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23177A2492023-06-230Issue date: 23 June 2023 Title: Comment (012) from Thomas Basso on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23171B0022023-06-160Issue date: 16 June 2023 Title: Comment (010) from Amy C. Chamberlain on Behalf of the Southern Nuclear Operating Company on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23171B0032023-06-150Issue date: 15 June 2023 Title: Comment (011) from Thomas Basso on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23157A0252023-06-020Issue date: 2 June 2023 Title: Comment (018) from Dr. Carol S. Marcus on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23128A2782023-05-050Issue date: 5 May 2023 Title: Comment (007) from David P. Helker on Behalf of Constellation Energy Generation, LLC on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23095A0372023-04-040Issue date: 4 April 2023 Title: Comment (001) from Mark A. Richter on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23093A1872023-04-030Issue date: 3 April 2023 Title: Comment (005) from David M. Gullott on Behalf of Constellation Energy Generation, LLC on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 ML23093A1882023-03-310Issue date: 31 March 2023 Title: Comment (003) from Dr. Jennifer L. Uhle on Behalf of the Nuclear Energy Institute on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 NRC-2021-0024, Comment (004) from Richard J. Freudenberger on Behalf of BWXT Nuclear Operations Group, Inc. - Lynchburg on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 20232023-03-310Issue date: 31 March 2023 Title: Comment (004) from Richard J. Freudenberger on Behalf of BWXT Nuclear Operations Group, Inc. - Lynchburg on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 ML23080A1872023-03-200Issue date: 20 March 2023 Title: Comment (002) from Dr. Adam Stein and Leigh Ann Lloveras on Behalf of the Breakthrough Institute on PR-30, 40, 50, 70 & 72 - Alternatives to the Use of Credit Ratings ML23080A1862023-03-170Issue date: 17 March 2023 Title: Comment (001) from Douglas E. True on Behalf of the Nuclear Energy Institute on PR-30, 40, 50, 70 & 72 - Alternatives to the Use of Credit Ratings ML23074A0712023-03-140Issue date: 14 March 2023 Title: Comment (007) from Ralph Meyer on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23060A4902023-02-270Issue date: 27 February 2023 Title: Declaration of Linda Hanratty in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23061A1282023-02-230Issue date: 23 February 2023 Title: Comment (004) from Gayle Elliott on Behalf of Framatome, Inc. on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23044A6222023-02-130Issue date: 13 February 2023 Title: Notice of Appearance of William David Griggs ML23038A2302023-02-060Issue date: 6 February 2023 Title: Limited Appearance Statement from Angela Couch in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML24355A1422023-02-010Issue date: 1 February 2023 Title: NIST Center for Neutron Research (NCNR) Submittal of Request for Exigent License Amendment Under 10CFR50.91(a)(6) to Make Specified Changes to Nbsr Safety Analysis Report ML23038A2292023-01-310Issue date: 31 January 2023 Title: Limited Appearance Statement from Veronica Cox in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23060A5002023-01-300Issue date: 30 January 2023 Title: Declaration of Anita Smith in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23060A4982023-01-300Issue date: 30 January 2023 Title: Declaration of Janet Mattern in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23060A4882023-01-300Issue date: 30 January 2023 Title: Declaration of Margaret Demoss in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23038A2272023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Steve Cox in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23038A2282023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Curtis Anthony in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23038A2262023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Diane Mccarter in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23031A2022023-01-300Issue date: 30 January 2023 Title: Comment (005) from David M. Gullott on Behalf of Constellation Energy Generation, LLC on PR-50 - Reporting Requirements for Nonemergency Events at Nuclear Power Plants ML23060A4972023-01-300Issue date: 30 January 2023 Title: Declaration of Terry Mcintire in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23026A2132023-01-260Issue date: 26 January 2023 Title: Notice of Appearance by Richard Mckay on Behalf of Eureka County, Nv ML23026A2142023-01-260Issue date: 26 January 2023 Title: Certificate of Service for Notice of Appearance of Richard Mckay ML23027A0422023-01-260Issue date: 26 January 2023 Title: Limited Appearance Statement from Duane F. Creger in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23027A0382023-01-260Issue date: 26 January 2023 Title: Limited Appearance Statement from Joan Skewes Boone in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A4032023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Brian Rosecrance in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A3802023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Joan Seeman in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A0802023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Anna Ikeda in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23023A2752023-01-230Issue date: 23 January 2023 Title: Request for Extension of Comment Period from the Nuclear Energy Institute on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23004A0362022-12-300Issue date: 30 December 2022 Title: Comment (002) from Jeffrey Semancik on Behalf of the Nuclear Energy Advisory Council on PR-50 - Reporting Requirements for Nonemergency Events at Nuclear Power Plants ML22333A7332022-11-280Issue date: 28 November 2022 Title: Comment (011) from Wayne Norton on Behalf of the Decommissioning Plant Coalition on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7352022-11-280Issue date: 28 November 2022 Title: Comment (013) from the State of Wisconsin Department of Health and Human Services on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7322022-11-280Issue date: 28 November 2022 Title: Comment (010) from Michael J. Guastella on Behalf of the Council on Radionuclides and Radiopharmaceuticals, Inc. on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7312022-11-220Issue date: 22 November 2022 Title: Comment (009) from the Department of Energy, National Nuclear Security Administration on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards NRC-2016-0179, Comment (016) from Global Nuclear Fuel-Americas, LLC on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards2022-11-170Issue date: 17 November 2022 Title: Comment (016) from Global Nuclear Fuel-Americas, LLC on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22301A1932022-10-280Issue date: 28 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Attachment 1 ML22301A1942022-10-270Issue date: 27 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Attachment 2 ML22301A1912022-10-270Issue date: 27 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Letter NRC-2022-0097, Redacted Version of Request for Access to SUNSI Information by Park Overall Regarding Nuclear Fuel Services License Amendment Application2022-09-140Issue date: 14 September 2022 Title: Redacted Version of Request for Access to SUNSI Information by Park Overall Regarding Nuclear Fuel Services License Amendment Application ML22223A0642022-08-090Issue date: 9 August 2022 Title: Comment (040) from New York State Senator James Skoufis on PR-20, 26, 50, 51, 52, 72, 73 and 140 - Regulatory Improvements for Production and Utilization Facilities Transitioning to Decommissioning ML22180A0322022-06-270Issue date: 27 June 2022 Title: Comment (006) from the Council on Radionuclides and Radiopharmaceuticals, Inc., on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22180A0332022-06-270Issue date: 27 June 2022 Title: Comment (007) from the Health Physics Society on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22178A2052022-06-240Issue date: 24 June 2022 Title: Comment (002) from the Low-Level Radioactive Waste Forums Disused Sources Working Group on Pr 30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22178A2042022-06-240Issue date: 24 June 2022 Title: Comment (003) from Eli Lilly and Company on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML23332A1912021-11-150Issue date: 15 November 2021 Title: Exhibit 10 - FPL Year 3 Raasr Final ML21175A1602021-06-220Issue date: 22 June 2021 Title: Comment (005) from the Western Interstate Energy Board High-Level Radioactive Waste Committee on PRM-37-2 - Advance Tribal Notification of Certain Radioactive Material Shipments ML21175A3572021-06-070Issue date: 7 June 2021 Title: Comment (009) from Governor Stuart Paisano on Behalf of Pueblo of Sandia, Nm on PRM-37-2 - Advance Tribal Notification of Certain Radioactive Material Shipments ML21141A3282021-05-210Issue date: 21 May 2021 Title: Nuclear Information and Resource Services Request for Extension of Hearing Request and Comment Deadline (NRC-2021-0099) ML21140A4102021-05-200Issue date: 20 May 2021 Title: Certificate of Service ML21140A4092021-05-200Issue date: 20 May 2021 Title: Environmental Law and Policy Centers Motion to Extend Deadline for All Hearing Requests Regarding Exelon Generation Company, LLCs Facility Operating License Transfer Application ML21098A2452021-04-050Issue date: 5 April 2021 Title: Comment (010) from Patrick Vibien on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21103A3372021-04-050Issue date: 5 April 2021 Title: Comment (011) from Edwin S. Lyman on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A1012021-04-030Issue date: 3 April 2021 Title: Comment (007) from the American Society of Mechanical Engineers on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A1002021-04-010Issue date: 1 April 2021 Title: Comment (006) from the Nuclear Energy Institute on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A0982021-04-010Issue date: 1 April 2021 Title: Comment (005) from Alexander Tsirigotis on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21090A3412021-03-310Issue date: 31 March 2021 Title: Cape Cod Time Article - Pilgrim Np Moves Spent Nuclear Fuel to Higher Elevation ML21095A0972021-03-300Issue date: 30 March 2021 Title: Comment (004) from Chakrapani Basavaraju on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A0962021-03-290Issue date: 29 March 2021 Title: Comment (003) from Chakrapani Basavaraju on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21141A3302021-03-290Issue date: 29 March 2021 Title: Comment (023) from Mimi Estrada Regarding PR-026 - Fitness for Duty Drug Testing Requirements ML21075A3222021-03-160Issue date: 16 March 2021 Title: Comment (485) from Daniel Fass on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21046A0692021-02-160Issue date: 16 February 2021 Title: Release. Nuclear Watchdog Alleges Three Mile Island Is in Violation of the Clean Water Act ML21046A0682021-02-160Issue date: 16 February 2021 Title: Agency Notification. Three Mile Island Is in Violation of the Clean Water Act Section 401 Certification Rule ML21034A5992021-02-030Issue date: 3 February 2021 Title: Comment (001) from Mark Moenssens on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21048A3602021-02-010Issue date: 1 February 2021 Title: Comment (004) of Ellen C. Ginsberg on Behalf of the Nuclear Energy Institute on PR-1 - NRC Enforcement Policy ML21048A3592021-01-280Issue date: 28 January 2021 Title: Comment (003) from Anonymous of on PR-1 - NRC Enforcement Policy ML21046A0702021-01-270Issue date: 27 January 2021 Title: Enclosure. Before the Srbc, (Testimony of Eric J. Epstein, December 11, 2020) ML21048A3582021-01-250Issue date: 25 January 2021 Title: Comment (002) of Stephen Cowne on Behalf of Louisiana Energy Services, LLC on PR-1 - NRC Enforcement Policy ML20364A1292020-12-290Issue date: 29 December 2020 Title: Letter from Dr. Fred Dilger, State of Nevada - Office of the Governor, Agency for Nuclear Projects, Providing Updated Nevada LSNARP Information ML21015A4162020-11-300Issue date: 30 November 2020 Title: Comment (453) from David Lewis on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5042020-11-300Issue date: 30 November 2020 Title: Comment (483) from Martha Silva on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3332020-11-300Issue date: 30 November 2020 Title: Comment (464) from William White on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3342020-11-300Issue date: 30 November 2020 Title: Comment (465) from Martin Tornai on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2672020-11-300Issue date: 30 November 2020 Title: Comment (372) from Valerie Jewells on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21015A4122020-11-300Issue date: 30 November 2020 Title: Comment (449) of Tonia E. Bryant on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3292020-11-300Issue date: 30 November 2020 Title: Comment (460) from Zachary Scherzer on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2692020-11-300Issue date: 30 November 2020 Title: Comment (374) from Angie D. Morgan Hill on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21019A3352020-11-300Issue date: 30 November 2020 Title: Comment (466) from Josh Mailman on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3412020-11-300Issue date: 30 November 2020 Title: Comment (471) from Max Cid on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3322020-11-300Issue date: 30 November 2020 Title: Comment (463) from the Association for Vascular Access on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5052020-11-300Issue date: 30 November 2020 Title: Comment (484) from Tracy King on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A4942020-11-300Issue date: 30 November 2020 Title: Comment (473) from the Organization of Agreement States on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3382020-11-300Issue date: 30 November 2020 Title: Comment (469) from Wendy Young on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5022020-11-300Issue date: 30 November 2020 Title: Comment (481) from Joshy Kallarackal on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3302020-11-300Issue date: 30 November 2020 Title: Comment (461) by Anonymous Individual on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3282020-11-300Issue date: 30 November 2020 Title: Comment (459) from Karl Fischer on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5032020-11-300Issue date: 30 November 2020 Title: Comment (482) from Josh Knowland on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3392020-11-300Issue date: 30 November 2020 Title: Comment (470) from Jagadesh Singh on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2712020-11-300Issue date: 30 November 2020 Title: Comment (376) from Marija Ivanovic on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21019A3372020-11-300Issue date: 30 November 2020 Title: Comment (468) from William Gorge on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3362020-11-300Issue date: 30 November 2020 Title: Comment (467) from Katie Martinez on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20335A4842020-11-270Issue date: 27 November 2020 Title: Comment (367) from Laura Weil on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4852020-11-270Issue date: 27 November 2020 Title: Comment (368) from Darrell R. Fisher on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20353A3832020-11-270Issue date: 27 November 2020 Title: Comment (429) from Deepak Kanda on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3222020-11-250Issue date: 25 November 2020 Title: Comment (427) from Keith T. Kirk on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3192020-11-240Issue date: 24 November 2020 Title: Comment (424) from Michelle Bates on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3112020-11-220Issue date: 22 November 2020 Title: Comment (417) from Michael Matyas on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3092020-11-210Issue date: 21 November 2020 Title: Comment (415) from Max Nikitchenko on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1532020-11-200Issue date: 20 November 2020 Title: Comment (411) from Herbert Medford on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1472020-11-200Issue date: 20 November 2020 Title: Comment (405) from Terry Vomocil on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1502020-11-200Issue date: 20 November 2020 Title: Comment (408) from Katrina Underwood on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20335A4762020-11-180Issue date: 18 November 2020 Title: Comment (360) from Kelly Mcchuen on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4772020-11-180Issue date: 18 November 2020 Title: Comment (361) from Beth Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4802020-11-180Issue date: 18 November 2020 Title: Comment (363) from Stephanie Obrien on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4792020-11-180Issue date: 18 November 2020 Title: Comment (362) from Beth Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4822020-11-180Issue date: 18 November 2020 Title: Comment (365) from Kathy Ellefson on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4812020-11-180Issue date: 18 November 2020 Title: Comment (364) from Melany White on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4832020-11-180Issue date: 18 November 2020 Title: Comment (366) from Ashley Vander Poel on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4722020-11-160Issue date: 16 November 2020 Title: Comment (357) from Vijay Yerubandi on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4742020-11-160Issue date: 16 November 2020 Title: Comment (359) from Anthoula Lykouretzos on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3622020-11-150Issue date: 15 November 2020 Title: Comment (346) from Daniel Gorge on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3612020-11-150Issue date: 15 November 2020 Title: Comment (345) from Chirayu Shah on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3292020-11-140Issue date: 14 November 2020 Title: Comment (341) from David Williams on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3592020-11-140Issue date: 14 November 2020 Title: Comment (343) from Bennett S. Greenspan on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3582020-11-140Issue date: 14 November 2020 Title: Comment (342) from Tomy Kalapparambath on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3602020-11-140Issue date: 14 November 2020 Title: Comment (344) from Ron Schmitt on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3272020-11-130Issue date: 13 November 2020 Title: Comment (339) from Lisabeth Hammerlund on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3252020-11-130Issue date: 13 November 2020 Title: Comment (337) from Nancy Mcdonald on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3282020-11-130Issue date: 13 November 2020 Title: Comment (340) from Robert Wystepek on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20317A2882020-11-080Issue date: 8 November 2020 Title: Comment (321) from Michael Blandina on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20317A2872020-11-070Issue date: 7 November 2020 Title: Comment (320) from Delphine Chen on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20317A2862020-11-060Issue date: 6 November 2020 Title: Comment (319) from Christina Faz on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A3312020-10-280Issue date: 28 October 2020 Title: Comment (294) from Tiffinee Swanson on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A3332020-10-280Issue date: 28 October 2020 Title: Comment (295) from Meryl Gorge on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1392020-10-260Issue date: 26 October 2020 Title: Comment (277) from Dawn Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1372020-10-260Issue date: 26 October 2020 Title: Comment (275) from Glenn Bendall on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1432020-10-260Issue date: 26 October 2020 Title: Comment (281) from Ashley Thomas on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1492020-10-260Issue date: 26 October 2020 Title: Comment (286) from Dalton Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1512020-10-260Issue date: 26 October 2020 Title: Comment (288) from Lauren Shanbrun on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1442020-10-260Issue date: 26 October 2020 Title: Comment (282) from Anna Kerr on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1352020-10-260Issue date: 26 October 2020 Title: Comment (273) from Myla Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1362020-10-260Issue date: 26 October 2020 Title: Comment (274) from Kimberly Hogan on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1402020-10-260Issue date: 26 October 2020 Title: Comment (278) from Tammra Bryant on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1542020-10-260Issue date: 26 October 2020 Title: Comment (291) from Marjan Boerma on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1472020-10-260Issue date: 26 October 2020 Title: Comment (284) from Cecilia Pauley on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1382020-10-260Issue date: 26 October 2020 Title: Comment (276) from Jordan Case on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1412020-10-260Issue date: 26 October 2020 Title: Comment (279) from Heather Case on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20301A8102020-10-240Issue date: 24 October 2020 Title: Comment (255) from Lisa Haskell on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A5282020-10-230Issue date: 23 October 2020 Title: Comment (252) from Julie Taylor on on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3902020-10-230Issue date: 23 October 2020 Title: Comment (251) from Rupa Shah on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3652020-10-220Issue date: 22 October 2020 Title: Comment (243) from Mike Winter on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3872020-10-220Issue date: 22 October 2020 Title: Comment (248) from Joshua Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5322020-10-210Issue date: 21 October 2020 Title: Comment (212) from Laura Peterson on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5902020-10-210Issue date: 21 October 2020 Title: Comment (225) from Guadalupe Medina on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML21034A5752020-10-210Issue date: 21 October 2020 Title: Comment (1828) of Jeff Ruch, on Behalf of Public Employees for Environmental Responsibility (Peer), Opposing Transfer of Very Low-Level Waste to Exempt Persons for Disposal ML20296A5272020-10-210Issue date: 21 October 2020 Title: Comment (207) from Laura Wotta on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5292020-10-210Issue date: 21 October 2020 Title: Comment (209) from Glenn Carney on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3462020-10-210Issue date: 21 October 2020 Title: Comment (230) from Elizabeth Farmer on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5882020-10-210Issue date: 21 October 2020 Title: Comment (223) from Chung Lee on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3452020-10-210Issue date: 21 October 2020 Title: Comment (229) from Lori Bachteler on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3432020-10-210Issue date: 21 October 2020 Title: Comment (227) from Quang Tran on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5812020-10-210Issue date: 21 October 2020 Title: Comment (216) from Benjamin Meyer on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5242020-10-210Issue date: 21 October 2020 Title: Comment (204) from Hung Dam on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3442020-10-210Issue date: 21 October 2020 Title: Comment (228) from Michael Connelly on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5872020-10-210Issue date: 21 October 2020 Title: Comment (222) from Edwin Goldstein on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3422020-10-210Issue date: 21 October 2020 Title: Comment (226) from Mike Roman on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5222020-10-200Issue date: 20 October 2020 Title: Comment (202) from Daniel Sullivan on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5212020-10-200Issue date: 20 October 2020 Title: Comment (201) from Anonymous on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5232020-10-200Issue date: 20 October 2020 Title: Comment (203) from Melissa Blake on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20293A5032020-10-160Issue date: 16 October 2020 Title: Comment (150) from Heather Merchantz on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A6122020-10-090Issue date: 9 October 2020 Title: Comment (113) from Adeara Bianchi on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A5092020-10-090Issue date: 9 October 2020 Title: Comment (109) from Melissa Arturet on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A6132020-10-090Issue date: 9 October 2020 Title: Comment (114) from Terri Crockett on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A5022020-10-090Issue date: 9 October 2020 Title: Comment (102) from Michael Yu on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A3942020-10-080Issue date: 8 October 2020 Title: Comment (092) from Lisa Patrick on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7452020-10-080Issue date: 8 October 2020 Title: Comment (039) from David Schuster on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A5002020-10-080Issue date: 8 October 2020 Title: Comment (100) from Fatma Ahmed on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3612020-10-080Issue date: 8 October 2020 Title: Comment (059) from Michelle Flynn on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A3662020-10-080Issue date: 8 October 2020 Title: Comment (064) from Jeremy Heinrich on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20289A3962020-10-080Issue date: 8 October 2020 Title: Comment (094) from Caban Tarte on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3642020-10-080Issue date: 8 October 2020 Title: Comment (062) from Heather Lavinder on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7752020-10-080Issue date: 8 October 2020 Title: Comment (087) from Kevin Beal on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3692020-10-080Issue date: 8 October 2020 Title: Comment (067) from David Knell on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7632020-10-080Issue date: 8 October 2020 Title: Comment (076) from Maria Nolan on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7482020-10-080Issue date: 8 October 2020 Title: Comment (042) from Terry Roy on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3702020-10-080Issue date: 8 October 2020 Title: Comment (068) from Anne Schofield on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7662020-10-080Issue date: 8 October 2020 Title: Comment (079) from Glowingrainbow Woods on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7582020-10-080Issue date: 8 October 2020 Title: Comment (052) from Lindsey Meadows on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7462020-10-080Issue date: 8 October 2020 Title: Comment (040) from Arthur Schnitzer on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3602020-10-080Issue date: 8 October 2020 Title: Comment (058) from Moira Pouls on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20283A7472020-10-080Issue date: 8 October 2020 Title: Comment (041) from Nancy Mcdonald on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7542020-10-080Issue date: 8 October 2020 Title: Comment (048) from Phyllis Tesluk on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7672020-10-080Issue date: 8 October 2020 Title: Comment (080) from Mohammad S. Qurashi on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7562020-10-080Issue date: 8 October 2020 Title: Comment (050) from James Gannon on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A4022020-10-080Issue date: 8 October 2020 Title: Comment (099) from Luis Tamara on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7772020-10-080Issue date: 8 October 2020 Title: Comment (089) from Bill Decker on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7552020-10-080Issue date: 8 October 2020 Title: Comment (049) from Richard Chandler on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7652020-10-080Issue date: 8 October 2020 Title: Comment (078) from Sofiya Yovanic on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3672020-10-080Issue date: 8 October 2020 Title: Comment (065) from Togustine Nguyen on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7722020-10-080Issue date: 8 October 2020 Title: Comment (085) from Fletcher Macomb on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3622020-10-080Issue date: 8 October 2020 Title: Comment (060) from Michelle Wanner on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7762020-10-080Issue date: 8 October 2020 Title: Comment (088) from Mary Beth Farrell on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7622020-10-080Issue date: 8 October 2020 Title: Comment (075) from Mary Bardelli on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3572020-10-080Issue date: 8 October 2020 Title: Comment (055) from Scott Mckoin on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7642020-10-080Issue date: 8 October 2020 Title: Comment (077) from Robert Flavell on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A4002020-10-080Issue date: 8 October 2020 Title: Comment (097) from Jamie Casey on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7492020-10-080Issue date: 8 October 2020 Title: Comment (043) from Melissa Snody on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3712020-10-080Issue date: 8 October 2020 Title: Comment (069) from Michael Blandina on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A3752020-10-080Issue date: 8 October 2020 Title: Comment (073) from Susan Staten on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20282A4332020-10-060Issue date: 6 October 2020 Title: Comment (037) from Peter Borotto on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events 2025-09-11 |
Retrieved from "https://kanterella.com/w/index.php?title=NRC/SECY/RAS&oldid=607630"